Yeda Research and Develpment & Co. Ltd

Ramot at Tel-aviv University Ltd.

Nice Systems Ltd.

Daniel Harari

Yosef Yarden

Igal Dvir

Nahum Kiryati

Shimon Ullman

Liav Assif

Yan Ivanchenko

Shay Rochel

Igal Koifman

Tamar Riklin-Raviv

A multi-layer viewing system includes a stationary imager and a beam projector to project physical layer markings onto a region of an object. A headset includes an augmented reality display that is sufficiently transparent to enable a user who is wearing the headset to directly view the object through the display, and to display annotation that is superimposed on the object. A processor is configured to receive a selected location relative to the target for display of the annotation, determine an orientation of the augmented reality display by identifying images of markings in acquired images or markings on the object, calculate a display location for displaying the annotation on the augmented reality display such that the annotation is perceivable by the user as displayed at the selected position, and display the annotation at the calculated display location.

Augmented reality display system and method

An apparatus and method for detection of abnormal motion in video stream, having a training phase for defining normal motion and a detection phase for detecting abnormal motions in the video stream is provided. Motion is detected according to motion vectors and motion features extracted from video frames.

Apparatus and methods for the detection of abnormal motion in a video stream

The present invention provides for isolated polypeptides capable of binding ErbB-4.

Growth factor which acts through ErbB-4 RTK

A novel ErbB-4 ligand, referred to herein as Neuregulin-4 (NRG-4) is disclosed as well as polynucleotide sequences encoding NRG-4, oligonucleotides and oligonucleotide analogs derived from polynucleotide sequences, a display library displaying short peptides derived from NRG-4, antibodies recognizing NRG-4, peptides or peptide analogs derived from NRG-4, and pharmaceutical compositions and methods of employing peptides or peptide analogs, oligonucleotides and oligonucleotide analogs, and/or polynucleotide sequences to up-regulate or down-regulate ErbB-4 receptor activity (signaling).

Growth factor which acts through erb b-4 rtk

Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine

Growing community of inventors

Rehovot, Israel

Daniel Harari